Cinctive Capital Management LP Evelo Biosciences, Inc. Transaction History

Cinctive Capital Management LP

  • $1.72 Billion
  • Q3 2024

A detailed history of Cinctive Capital Management LP transactions in Evelo Biosciences, Inc. stock. As of the latest transaction made, Cinctive Capital Management LP holds 102,900 shares of EVLO stock, worth $0. This represents 0.04% of its overall portfolio holdings.

Number of Shares
102,900
Holding current value
$0
% of portfolio
0.04%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email